Evidence map›Paper›PMID 19640980›Full record

ArticleJournal of virology2009

T-cell vaccination reduces simian immunodeficiency virus levels in semen.

James B Whitney, Corinne Luedemann, Peter Hraber, Srinivas S Rao, John R Mascola, Gary J Nabel, Norman L Letvin

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

James B WhitneyDivision of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Corinne Luedemann
Peter Hraber
Srinivas S Rao
John R Mascola
Gary J Nabel
Norman L Letvin
Harvard University · USNational Institute of Allergy and Infectious Diseases · USLos Alamos National Laboratory · US

Funding

Non Human Primate Models of SIV and HIV Immune ProtectionZIAAI005009 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MASCOLA, JOHN · 2009 to 2018
$5.8M
Passive Antibody Protection In The Setting Of Active CelZ01AI005009 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI MASCOLA, JOHN R · 2002 to 2008
$523k
Intramural NIH HHS
6 · The paper itself

Abstract

Recent findings suggest that most sexual transmission of human immunodeficiency virus type 1 (HIV-1) occurs during the acute phase of infection when viral replication is most intense. Here, we show that vaccine-elicited cellular immune responses can significantly reduce simian immunodeficiency virus levels in the semen during the period of primary infection in monkeys. A vaccine that decreases the quantity of HIV-1 in the semen of males during primary infection might decrease HIV-1 transmission in human populations and therefore affect the spread of AIDS.

Indexed as

AnimalsGene Products, gagGene Products, polHumansLymphocyte ActivationMacaca mulattaMaleReverse Transcriptase Polymerase Chain ReactionRNA, ViralSAIDS VaccinesSemenSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-LymphocytesVaccinationViral LoadGene Products, gagGene Products, polRNA, ViralSAIDS Vaccines

Identifiers

PMID19640980
PMCPMC2753121
OpenAlexW2102022357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.